Sonnet to present at the medinvest biotech & pharma conference

Princeton, n.j., sept. 19, 2025 (globe newswire) -- sonnet biotherapeutics holdings, inc. (nasdaq:sonn) (the "company" or "sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment (tme), today announced that raghu rao, interim chief executive officer of sonnet, will present on thursday, september 25, 2025 at 9:40 am pt at the medinvest biotech & pharma conference being held in palo alto, california.
SONN Ratings Summary
SONN Quant Ranking